Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
申请人:Bristol-Myers Squibb Company
公开号:US06350892B1
公开(公告)日:2002-02-26
Selective inhibitors of the cPLA2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases. The inhibitors of the present invention have the general formula
where (R′), p, D, Y, Z, Ra, Rb and A are as defined in the specification.